Liver cancer (primary or secondary)
Conditions
Brief summary
TNR improvement factor: the TNR after AT-II infusion with subsequent direct 90Y microsphere injection as measured on 90Y PET/CT divided by the TNR after 99mTc-MAA without AT-II infusion as measured on SPECT/CT.
Detailed description
Toxicity profile of combining 90Y radioembolization with AT-II infusion (graded according to CTCAE v5.0), Technical success of AT-II infusion. Technical success is defined as the successful intra-arterial administration of AT-II (10 μg/min for 100 seconds) followed by immediate 90Y glass microsphere injection.
Interventions
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TNR improvement factor: the TNR after AT-II infusion with subsequent direct 90Y microsphere injection as measured on 90Y PET/CT divided by the TNR after 99mTc-MAA without AT-II infusion as measured on SPECT/CT. | — |
Secondary
| Measure | Time frame |
|---|---|
| Toxicity profile of combining 90Y radioembolization with AT-II infusion (graded according to CTCAE v5.0), Technical success of AT-II infusion. Technical success is defined as the successful intra-arterial administration of AT-II (10 μg/min for 100 seconds) followed by immediate 90Y glass microsphere injection. | — |
Countries
Netherlands
Outcome results
None listed